2. Acromegaly is a disorder that results from
excess growth hormone (GH) after the
growth plates have closed
•Acr/o = extremities.
•-megaly= enlargement.
•Rare disease of the pituitary gland in the
brain.
•Caused by a benign tumor.
3. Pituitary gland is a pea-
sized gland that releases
and regulates several
hormones, including
human growth hormone
(HGH) that is responsible
for regulating growth.
4. It is not uncommon to find pituitary
tumors. 1 out of 10 people have tiny
tumors in the pituitary gland (pituitary
adenoma), but only 3.5 per million
people develop acromegaly
About 98% of cases of acromegaly are
due to the overproduction of growth
hormone by a benign tumor of the
pituitary gland called an adenoma
Other tumors. tumors of the pancreas,
lungs, and adrenal glands
5. If the hypersecretion
of HGH occurs before
to epiphyseal plate
closes at puberty, it is
called gigantism.
Gigantism causes a
growth in height,
whereas acromegaly
causes one's features
and extremities to
grow larger and wider.
6. Symptoms include changes in voice
Changes in face features, such as jaw, nose,
and forehead
Excessive facial hair in women
7.
8. Enlarged tongue, hands, and feet.
Weight gain
Joint pain and muscle weakness.
10. Sleep apnea
Arthriris and carpal
tunnel syndrome
Infertility
Vision loss
Fatigue
11. Magnetic resonance imaging (MRI)
or computed tomography (CT)
scan
Blood test for elevated level of GH
or somatomedin-C (IGF-1)
In normal subjects, plasma GH
suppresses to below 0.5 µg/L
(approximately 2 mU/L).In
acromegaly, GH does not suppress
and in about 30%of patients there
is a paradoxical rise; IGF-1 is also
elevated
12. Trans-sphenoidal surgery
is usually the frst line of
treatment and may result
in cure of GH excess
Treatment is successful
depending on the size of
the tumor1 cm by 1 cm in
size has a higher cure rate
Larger size tumors lower
the cure rate
Surgical removal of the
tumor.
13. Gamma Knife cobalt
Cyber Knife
Hormone-regulating therapy
Somatostatin analogues (such
as octreotide or lanreotide)
14. Pegvisomant is a peptide GH
receptor antagonist administered
by daily self-injection and may be
indicated in some patients whose
GH and IGF-1 concentrations fail
to suppress suffciently following
somatostatin analogue therapy
Dopamine agonists are less
effective at lowering GH but may
sometimes be helpful
15. HGH levels and soft tissue* enlargement are
not expected to return to normal right away.
*Note bony tissue growth cannot be undone.